Hall et al. showed that genetic variation in catechol-O-methyltransferase (COMT), a key enzyme in estrogen and catecholamine metabolism, and the COMT rs4818G allele was associated with lower cardiovascular disease risk and lower fibrinogen levels [42]. Here, COMT is linked to cardiovascular disorder.